Clinical Trials on Androgenetic Alopecia (AGA) in Japan
Total 61 results
-
GlaxoSmithKlineCompletedAndrogenetic AlopeciaJapan, Argentina, Peru, Philippines, Taiwan, Mexico, Chile, Russian Federation, Thailand
-
Hamamatsu UniversityUnknown
-
GlaxoSmithKlineCompleted
-
Janssen Research & Development, LLCWithdrawnAlopecia AreataUnited States, Japan, France, Australia
-
Eli Lilly and CompanyRecruitingSkin Diseases | Pathological Conditions, Anatomical | Alopecia | Hypotrichosis | Hair Diseases | Areata AlopeciaUnited States, Taiwan, Japan, Spain, Korea, Republic of, Germany, France, Mexico, Canada, Poland, Australia, Hungary, Argentina
-
Bristol-Myers SquibbActive, not recruitingAlopecia AreataCanada, France, Japan, Australia, United States, Poland
-
Kyowa Kirin Co., Ltd.TerminatedHealthy Volunteers | Wet Age-related Macular DegenerationJapan
-
Mie UniversityUnknownExudative Age-related Macular DegenerationJapan
-
Nagoya City UniversityNovartisCompletedNeovascular Age-related Macular DegenerationJapan
-
Eli Lilly and CompanyIncyte CorporationActive, not recruitingAlopecia AreataUnited States, Puerto Rico, Japan, Mexico, Korea, Republic of
-
AbbVieRecruitingAlopecia AreataUnited States, Australia, Japan, Puerto Rico, New Zealand, China, Canada, Brazil, United Kingdom, Korea, Republic of, Chile
-
Eli Lilly and CompanyIncyte CorporationActive, not recruitingAlopecia AreataIsrael, China, United States, Puerto Rico, Korea, Republic of, Taiwan, Australia, Japan, Brazil, Argentina
-
Nagoya UniversityRohto Pharmaceutical Co., Ltd.Completed
-
Kumamoto UniversityCompletedAge-related Macular DegenerationJapan
-
PfizerCompletedAlopecia AreataChina, United States, Spain, Korea, Republic of, Taiwan, Canada, Australia, Germany, Czechia, Poland, Hungary, Japan, United Kingdom, Argentina, Chile, Colombia, Mexico, Russian Federation
-
PfizerActive, not recruitingAlopecia AreataUnited States, Spain, China, Korea, Republic of, Taiwan, Australia, Canada, Germany, Czechia, Poland, Japan, United Kingdom, Mexico, Argentina, Chile, Colombia, Russian Federation
-
NovartisCompletedSubfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)Japan
-
Nihon UniversityCompletedAge-related Macular DegenerationJapan
-
Osaka UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedAge Related Macular Degeneration | Neovascular MaculopathyJapan
-
Novo Nordisk A/SCompletedFoetal Growth Problem | Small for Gestational AgeJapan
-
AstraZenecaCompletedHealthy Japanese Children Age 2 Years Through 6 YearsJapan
-
Ophthalmic PDT Study GroupCompleted
-
Novo Nordisk A/SCompletedFoetal Growth Problem | Small for Gestational AgeJapan
-
Astellas Pharma IncOno Pharmaceutical Co. LtdCompletedOsteoporosis | Bone Loss, Age-RelatedJapan
-
Kagawa UniversityUnknownHypertension | Glomerulonephritis, IGAJapan
-
PfizerCompletedShort Stature Born Small for Gestational Age (SGA)Japan
-
Tokyo UniversityGoogle LLC.Enrolling by invitationCognitive Function | MCI | Cognition Disorders in Old Age | Frailty/SarcopeniaJapan
-
University of JazanCompletedAge-related Cognitive DeclineSaudi Arabia
-
Kyushu UniversityNovartis; Kurume University; Fukuoka University; University of Occupational and... and other collaboratorsUnknownVisual Disorder Due to Age-related Macula DegenerationJapan
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Novo Nordisk A/SActive, not recruitingShort Stature Children Born Small for Gestational Age (SGA)France, Russian Federation, United States, India, Spain, Estonia, Japan, Italy, Algeria, Austria, Hungary, Ireland, Israel, Latvia, Poland, Serbia, Thailand, Ukraine
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedIgA NephropathyUnited States, Japan, United Kingdom
-
Samsung Bioepis Co., Ltd.CompletedNeovascular Age-related Macular DegenerationCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Poland, United States, Croatia, Japan, Russian Federation
-
Bioeq GmbHCompletedNeovascular Age-related Macular DegenerationBulgaria, Italy, Poland, Russian Federation, Hungary, Ukraine, Japan, Israel, Czechia
-
Regeneron PharmaceuticalsTerminatedNeovascular Age-Related Macular DegenerationUnited States, Japan
-
Kyowa Kirin, Inc.RecruitingNeovascular Age-Related Macular Degeneration (nAMD)United States, Japan, Korea, Republic of, Australia
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationJapan
-
AstraZenecaCompletedHealthy Japanese Children Age 7 Years Through 18 YearsJapan
-
HI-BioActive, not recruitingImmunoglobulin A (IgA) NephropathyUnited Kingdom, Germany, Spain, Serbia, Taiwan, Australia, Japan, Korea, Republic of, Belgium, United States, Bulgaria, Czechia, Georgia, Malaysia, Philippines, Ukraine
-
Sam Chun Dang Pharm. Co. Ltd.CompletedNeovascular Age-related Macular Degeneration | Wet Age-related Macular DegenerationUnited States, Australia, Bulgaria, Czechia, Hungary, India, Israel, Japan, Korea, Republic of, Latvia, Poland, Russian Federation, Slovakia, Spain
-
SandozCompletedNeovascular Age-related Macular DegenerationUnited States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
-
AmgenParexelCompletedNeovascular (Wet) Age-related Macular Degeneration (AMD)Spain, United States, Czechia, Serbia, Israel, Canada, Germany, Japan, Hungary, Poland, Korea, Republic of, Estonia, Hong Kong, Italy, Latvia, Lithuania, Mexico, Slovakia
-
Novartis PharmaceuticalsRecruitingPrimary IgA NephropathyJapan, Korea, Republic of, United States, Denmark, France, Taiwan, Belgium, Israel, Thailand, Germany, India, Czechia, Malaysia, Argentina, Singapore, China, Australia, Norway, Turkey, United Kingdom, Brazil, Hong Kong, Netherlands, C... and more
-
BayerRegeneron PharmaceuticalsActive, not recruitingNeovascular Age-Related Macular DegenerationSpain, Korea, Republic of, Czechia, Japan, Singapore, United States, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Portugal, Bulgaria, Latvia, Canada, Hungary, Arge... and more
-
Novartis PharmaceuticalsCompletedIgA NephropathyColombia, Taiwan, Czechia, India, Turkey, Belgium, Netherlands, Singapore, Australia, Korea, Republic of, Thailand, Argentina, Germany, Israel, Japan, Sweden, United Kingdom, Brazil, China, Hong Kong, Norway, Finland, France, Denmark, M...
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
Hoffmann-La RocheRecruitingPrimary IgA NephropathyKorea, Republic of, Australia, Spain, United Kingdom, Taiwan, China, Japan, France, United States, Italy, Greece, Czechia, Singapore, Argentina, Germany, Brazil, Poland, Canada
-
Hoffmann-La RocheRecruitingDiabetic Macular Edema | Neovascular Age-related Macular DegenerationGermany, Croatia, Japan, United Kingdom, Spain, United States, Italy, Switzerland, Canada, France, Australia, Singapore, Israel, Puerto Rico, United Arab Emirates, Bulgaria, Chile, Czechia
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Polypoidal Choroidal VasculopathyJapan, Taiwan, Hong Kong, Singapore, Thailand, Korea, Republic of, Malaysia
-
Medtronic Cardiac Rhythm and Heart FailureCompletedClass I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National GuidelinesUnited States, Netherlands, Japan, Serbia, Spain, Greece, Canada, India, Denmark, Czechia, South Africa, Malaysia, Austria, United Kingdom, Hungary, China, Australia, France, Italy